Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Correspondence] Network meta-analysis of antidepressants

Cipriani and colleagues1 used re-sponse rate (a reduction of ≥50% of the total score) and dropout rate as their primary outcomes. The use of ranking scales for response rates is a misleading way to analyse data,2 which can inflate small differences between groups.3 The effect on the ranking scales was only a standardised mean difference of 0·30 (95% credible interval 0·26–0·34), which is far less than what is clinically relevant4 and is similar to the estimates reported in previous meta-analyses.